• Erastin: Precision Ferroptosis Inducer for Advanced Cancer R

  2026-04-25

  Erastin stands out as a rigorously validated ferroptosis inducer, enabling researchers to dissect iron-dependent, non-apoptotic cell death with high selectivity for RAS/BRAF-mutant tumor cells. This article bridges experimental workflows, troubleshooting strategies, and new mechanistic insights from landmark studies, positioning Erastin as a cornerstone for reproducible, high-impact cancer biology research.

• Bestatin Hydrochloride: Neuropeptide Circuitry and Tumor Mic

  2026-04-24

  Explore the unique role of Bestatin hydrochloride (Ubenimex) in dissecting neuropeptide-driven signaling and tumor microenvironment modulation. This article delivers a deep, evidence-based analysis that bridges neuroscience and cancer research for advanced assay development.

• RNA Pol II Inhibition Triggers Apoptosis Beyond Transcriptio

  2026-04-24

  Harper et al. (2025) uncover that cell death following RNA polymerase II inhibition is not due to passive mRNA depletion but results from an active, apoptosis-triggering signaling pathway initiated by the loss of hypophosphorylated RNA Pol IIA. This mechanistic insight reframes our understanding of transcriptional inhibition lethality and has implications for interpreting cytotoxic drug effects and designing targeted interventions.

• EZ Cap™ Firefly Luciferase mRNA: Optimized Reporter Workflow

  2026-04-23

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers robust, reproducible bioluminescent signals for gene regulation and mRNA delivery assays. Its advanced chemical design enhances translation and stability, giving researchers a reliable tool for sensitive in vitro and in vivo applications.

• Clozapine N-oxide: Precision Chemogenetics for Circuit Disco

  2026-04-23

  This thought-leadership article dissects the evolving role of Clozapine N-oxide (CNO) in enabling high-resolution, causal interrogation of neuronal circuits. By integrating mechanistic insights from landmark Alzheimer’s research and emerging chemogenetic strategies, we offer strategic guidance for translational scientists aiming to bridge preclinical models with human cognitive phenotypes. The discussion highlights APExBIO’s CNO as a gold-standard actuator, connects recent findings to disease-relevant circuit analysis, and charts a path for next-generation GPCR signaling research.

• Bufuralol Hydrochloride in Next-Gen Organoid Pharmacokinetic

  2026-04-22

  Bufuralol hydrochloride—a non-selective β-adrenergic receptor antagonist—unlocks new dimensions in cardiovascular pharmacology research. This article uniquely dissects its integration into human iPSC-derived intestinal organoids, offering advanced insight for β-adrenergic modulation studies.

• Levofloxacin: Applied Protocols in Osteoblast and DNA Replic

  2026-04-22

  Levofloxacin, a synthetic fluoroquinolone antibiotic, advances experimental rigor in both bacterial DNA replication inhibition and bone metabolism studies. This guide delivers actionable protocols, peer-reviewed troubleshooting, and workflow enhancements for leveraging Levofloxacin in cell-based and microbiological assays.

• Streptavidin-FITC: Precision Fluorescent Detection for Bioti

  2026-04-21

  Explore the scientific foundation and advanced applications of Streptavidin-FITC in sensitive biotin detection assays. Uncover mechanistic insights, protocol optimization, and how APExBIO’s conjugate elevates immunofluorescence and nanoparticle research.

• Redefining Cell Surface Proteomics: Sulfo-NHS-SS-Biotin in A

  2026-04-21

  This thought-leadership article explores how the Sulfo-NHS-SS-Biotin Kit (K1006) from APExBIO is revolutionizing surface proteomics and interactome mapping. Bridging mechanistic insight into glycoRNA-protein domains with actionable guidance, it positions reversible, water-soluble biotinylation at the heart of translational research, empowering breakthrough workflows in cell surface labeling, affinity purification, and dynamic interactome analysis.

• Mitoxantrone HCl: DNA Topoisomerase II Inhibitor in Oncology

  2026-04-20

  Mitoxantrone HCl stands apart as a dual-action DNA topoisomerase II inhibitor—offering robust DNA damage induction and allosteric nuclear receptor modulation. This article delivers stepwise workflows, advanced use-cases in leukemia and stem cell research, and actionable troubleshooting guidance for maximizing assay reliability.

• Cy5-UTP (Cyanine 5-UTP): Precision RNA Fluorescent Labeling

  2026-04-20

  Cy5-UTP (Cyanine 5-UTP) is a validated fluorescent uridine triphosphate analog for direct RNA labeling via in vitro transcription. Its use enables high-sensitivity probe synthesis for FISH and dual-color arrays, facilitating robust, orange-red fluorescence detection. This dossier details the mechanism, benchmarks, and integration of Cy5-UTP in molecular biology workflows.

• Cholecystokinin Octapeptide Ammonium: Receptor-Specific Neur

  2026-04-19

  Explore the receptor-specific mechanisms of Cholecystokinin octapeptide ammonium (CCK-8 ammonium) and its unique role in restoring neuroplasticity under opioid challenge. This article delivers a deep dive into CCK-8’s signaling, evidence-backed protocols, and how its nuanced actions inform next-generation neurobiological and behavioral assays.

• LLY-507: Potent SMYD2 Inhibitor for Cancer and Fibrosis Assa

  2026-04-18

  LLY-507, from APExBIO, sets a new standard for selective SMYD2 inhibition in both oncology and renal fibrosis research. Its high potency and target specificity empower precise dissection of SMYD2’s roles in cell proliferation, apoptosis, and fibrotic signaling, unlocking advanced experimental workflows.

• SCH772984 HCl: Benchmark ERK1/2 Inhibitor for MAPK Pathway R

  2026-04-17

  SCH772984 HCl is a nanomolar-potency ERK1/2 inhibitor with robust, selective activity in MAPK pathway studies. This compound is validated for use in BRAF- and RAS-mutant cancer research and enables precise modulation of ERK signaling with reproducible in vivo efficacy.

• Chemogenetic Modulation of Preoptic Gabre Neurons Alters Vit

  2026-04-16

  This study provides the first targeted analysis of Gabre-expressing neurons in the preoptic area, revealing their distinct roles in regulating body temperature and heart rate via chemogenetic manipulation in vivo. The findings refine our understanding of hypothalamic cell-type function in homeostatic control and highlight advanced chemogenetic tools for dissecting neural circuits.

16863 records 1/1125 page Next 12345 下5页 Last page